Clinical Trials Browser

Phase 3 × INDUSTRY × canakinumab × Clear all

Carcinoma, Non-Small-Cell Lung

NCT03626545 2023-08-21

CANOPY-2

Phase 3 Terminated

245 enrolled 29 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT02334748 2020-05-19

A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

Phase 3 Completed

31 enrolled 7 charts

Rheumatoid Arthritis, Systemic Juvenile, Bronchiolitis Obliterans Syndrome, Arthritis, Juvenile, Arthralgia, Mevalonate Kinase Deficiency, Cryopyrin-Associated Periodic Syndromes

NCT02911857 2018-08-20

An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes

Phase 3 Completed

4 enrolled 7 charts

Periodic Fevers Syndrome

Clinical Trials

Canopy-A

CANOPY-2

A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes